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Abstract
Background: Glioblastoma is refractory to conventional treatment, which is combined of surgery, chemotherapy
and radiotherapy. Recent studies have shown that glioma initiating cells (GICs) contribute to tumorigenesis and
radioresistance. Recently, other studies showed that the GICs use the autophagy as the major pathway to survive.
Chloroquine, an anti-malarial chemical, is an autophagic inhibitor which blocks autophagosome fusion with
lysosome and slows down lysosomal acidification. The aim of this study was to explore the mechanisms of
chloroquine on the radiosensitivity of GICs.
Methods: Human glioblastoma cell lines U87 were investigated. MTT and clonogenic survival assay were used to
evaluate the cell viability and survival from radiation. The formation of autophagosomes were evaluated by
immunofluorescence. Annexin V-FITC/PI staining and flow cytometry were used to quantify the apoptotic cells. The
expression levels of proteins were analyzed by Western blot. Cell cycle status was analyzed by checking DNA
content after staining with PI. A comet assay was used to assess the DNA repair in the cells. Tumorsphere assay was
used for evaluating GICs’ renewal ability.
Results: Treatment of U87 GICs with chloroquine (10–80 nmol/L) alone inhibited the cell growth in a dose-
dependent manner. A dose of chloroquine (20 nmol/L) obviously enhanced the radiation sensitivity of U87 GICs.,
we found more punctate patterns of microtubule-associated protein LC3 immunoreactivity in radiation-treated U87
GICs, and the level of membrane-bound LC3-II was obviously enhanced. A combination of radiation and
chloroquine obviously enhanced the U87 GICs’ apoptosis, as demonstrated by the enhanced levels of caspase-3,
and reduced level of Bcl-2. In additon, combination of radiation and chloroquine cause G1/G0 cell cycle arrest.
what’s more, Chloroquine obviously weakened the repair of radiation-induced DNA damage as reflected by the tail
length of the comet. Combination treatment of irradiation and chloroquine has synergistic effects on decreasing
the GICs’ tumorsphere number and diameter.
Conclusion: Chloroquine enhances the radiosensitivity of GICs in vitro, suggesting the feasibility of joint treatment
with chloroquine with radiation for GBM.
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Background
Glioblastoma (GBM) is the most malignant and com-
mon primary neoplasm in central nervous system. Des-
pite the advances in conventional treatments, comprised
of surgical resection, radiotherapy and chemotherapy,
the median duration of survival of GBM is 14.6 months
after first diagnosis [1]. Recent studies report that a mi-
nority subset of the whole glioma population is glioma
initiating cells (GICs), which led to tumorigenesis,
because these GICs show enhanced self-renewal ability,
multipotent differentiation that GICs can epitomize the
original tumor in vivo [2]. GICs are considered “seed”
cells and have strong radio-chemoresistance and tumori-
genic potential [3, 4]. Bao S et al. found primary tumor
cells are less radioresistant than GICs, and GICs were
responsible for tumor recurrence after radiotherapy [5].
Although surgery followed by radiation and chemother-
apy could eradicate most part of glioma cells, they did
not kill GICs. Thus, GICs are the novel cellular targets
and their elimination can hinder cancer progression and
recurrence.
Autophagy is also named type II programmed cell
death pathway, which is different from the apoptotic
type I death pathway [6]. Autophagy is a balance that
weights between reconstruction, energy equilibrium, cell
death and survival, correspondingly, with the internal or
external stimulations accepted. Autophagy has different
effects on tumor outcomes: it is essential for some forms
of cancer cell death, but it can help cancer growth by
assisting cancer cells fight hard cancer environment
(e.g., malnutrition, shortage of oxygen) and combat
radiotherapy and chemotherapy [7]. Yao found that ion-
izing radiation (IR) of human glioma cells led to
increased autophagy [8]. Other studies showed that the
induction of autophagy by radiotherapy result in the
radioresistance of GICs [9]. Therefore, discovery of a
novel combination treatment, such as radiotherapy or
chemotherapy combines autophagy suppression may be
a feasible and promising strategy.
Chloroquine is an anti-malaria drug, which has been
used for over eighty years. Recent years, choloroquine,
as an autophagy inhibitor, is drawing more and more
attentions [10]. Chloroquine-treated tumor cells are not
able to exploit autophagy as an substituting source of
energy and will die [11].
Researchers found that chloroquine combined with
chemo-radio-therapy, increased the duration of survival
of glioblastoma patients [12, 13]. However, other
researchers reported that the chloroquine treatment was
found not to be effective for the medical treatment of
malignant astrocytomas [14].
Therefore, the clinical effect of joint treatment with ra-
diation and chloroquine on the radioresistance of malig-
nant glioma and GICs remains uncertain. We investigate
the potential radiosensitization effect and its probable
mechanisms of chloroquine on GICs.
Methods
Preparation of CD133+ U87 GICs, cell culture, and
reagents
The human glioma cell lines U87 were purchased from
the Shanghai Institute of Biochemistry (Shanghai,
China). To isolate human CD133+ U87 GICs, Glioma
cell line U87 was cultured at 37 °C in the presence of
5 % CO2 in the medium containing 90 % Dulbecco’s
modified Eagle’s medium (DMEM) and 10 % Fetal Calf
Serum (FBS). After having digested with trypsin, resus-
pended, centrifuged, and purified by magnetic separation
using anti-CD133 microbeads (Miltenyi Biotec) per the
manufacturer’s instructions, CD133 negative cells were
also obtained at the same time and cultured in condi-
tions appropriate for growth. The human CD133+ U87
GICs, were then cultured at 37 °C in the presence of 5 %
CO2 in the serum-free DMEM/F12 culture medium,
supplemented with B27 (2 %), firoblast growth factor,
N2 supplement, and epidermal growth factor. The
medium was replaced every 3–5 days. We observed and
counted the attachment and suspension of cells twice
per day. Chloroquine was purchased from Sigma.
Cell viability assay
Cell viability was measured by MTT assays. Cells were
seeded in 96-well microplates (1 × 105 cells or 1 × 104
cells/well). After incubation at 37 °C in the presence of
5 % CO2 in constant temperature and humidity incuba-
tor for 3–5 days, the tumor cells were treated using dif-
ferent doses of chloroquine or radiotherapy alone or in
combination. We set up a control group and a zero
adjustment group. At specified time points, 20ul of
MTT solution (5 mg/mL) was added 4 h before the end
of the incubation duration, the reaction was stopped by
the addition of 150 μL dimethylsulfoxide (DMSO). The
optical density (OD) or absorbance was read at 490 nm.
X-rays
Radiation was performed using a 6-MV X-rays from a
linear accelerator (PRIMUS, DE, Siemens A&D LD,
Nelson Avenue Concord, USA).
Clonogenic assay
Cells were seeded in six-well plates (2 × 102 cells/well).
After 12 h incubation, cells were treated and irradiated.
After two weeks, the colonies were fixed with methanol
for 15 min and stained with 0.5 % crystal violet. Colonies
with at least 50 cells were counted.
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Immunofluorescence
The U87 GICs were plated onto coverslips and treated
with 20 μM/L concentration of chloroquine and 6 Gy
dose of radiation for 24 h. After fixation with 4 % para-
formaldehyde, tumor cells were incubated with blocking
buffer (0.1 % Triton X-100, 2 % horse serum) for 30 min
at 37 °C, and with the rabbit anti–human light chain 3
antibody (LC3) (1:200, Abcam) at 4 °C for overnight.
After wash, a secondary antibody (1:200) conjugated to
Alexa 488 (Invitrogen) was added and incubated for 1 h
at room temperature. Fluorescent cells were examined
with a confocal microscope to appraise the formation of
autophagosomes.
Western blot analysis
The cells were lysed with a lysis buffer (Beyotime,
Haimen, China), and centrifuged at 12,000 × g for
20 min. The total protein concentration was deter-
mined using the a BCA protein assay kit (Pierce).
Samples were resolved in SDS-PAGE, transferred to
0.45 μm nitrocellulose transfer membranes and ana-
lyzed separately. After blocking with 5 % skim milk at
room temperature for 60 min, the blots were survey
with primary antibodies against mouse anti-Bcl-2
(1:500; Abcam), rabbit anti-LC3 (1:1000; Abcam),
mouse anti-GAPDH (1:1000; Cell Signal), and rabbit
anti-active caspase-3 (1:1000; Abcam), at 4 °C for
overnight. We washed the membranes three times
with TBST buffer (20 mmol/L Tris-buffered saline
and 0.1 % Tween 20) for 1 h. And we used peroxid-
ase conjugated anti-mouse-IgG/anti rabbit-IgG as sec-
ondary antibodies. We did Chemiluminescence with
Amersham ECL plus Western blotting detection sys-
tem (GE healthcare). After washing with the TBST
buffer, the membranes were measured with the Odys-
sey Infrared Imaging System (LI-COR).
Flow cytometric apoptosis assay
The cells in the different treatment groups were mea-
sured using an Annexin V FITC Kit (Sigma, St Louis,
MO). Earlier stages apoptotic (annexin V+) (PI-) cells
were identified by flow cytometry on a BD FACS flow
cytometer (San Diego, CA).
Cell cycle analysis
5 × 105 cells per sample were collected after centrifuga-
tion at 1000 r.p.m for 5 min. The cells re-suspended
with 0.5 ml PBS and fixed with ice-cold 70 % ethanol
overnight at 4 °C. Fixed cells were washed with PBS and
stained with propidium at room temperature for 1 h.
The cells were subsequently measured by FACScan
(Becton-Dickinson, San Diego, CA, USA).
DNA damage
A comet assay quantitatively assesses DNA repair in
U87 GICs. The detailed procedure of the comet assay
performed in this experiment refers to the report of
Wang et al. [15]. The comet assay metric for DNA dam-
age induced by the treatment was tail DNA (%). We ana-
lyzed images from 50 cells (25 from each replicate slide).
Neurosphere assay
We trypsinized the U87 GICs and seeded equal numbers
of GICs in 48 well plates, and treated as indicated. Five
days after treatment, we counted total neurospheres
numbers and photographed.
Statistical analysis
The experimental data is showed as the mean ± SD.
All experiments were performed three times. Unpaired
Student’s t test was performed to analyses the significance
between experimental groups. Statistically significant P
values are indicated in the figures with asterisks: **, P <
0.01; *, P < 0.05. We used GraphPad software (Inc.; version
5.02) for all statistical analyses.
Results
Irradiation and chloroquine had synergetic effect on U87
GICs
The inhibitory effect of irradiation or chloroquine on
cell viability in GICs was evaluated after 72 h treatment.
As shown in Fig. 1a, a dose-dependent inhibitory action
on cell growing was assessed with irradiation or chloro-
quine alone. As shown in Fig. 1b, we seeded cells onto
96-well plates, and quantified the number of cells at in-
dicated time points by MTT assay. Irradition and chloro-
quine had synergistic inhibitory effect on U87 GICs.
Furthermore, We found that clonogenicity of U87 GICs
treated with radiation or radiation plus chloroquine were
obviously decreased in an radiation-dose dependent
manner (Fig. 1c). And the clonogenicity of the combined
group was significantly decreased, compared with radi-
ation treatment alone, suggesting chloroquine treatment
obviously enhanced radiation sensitivity in GICs. As
shown in Fig. 1d, there was obviously enhanced in the
number of cells in the G0/G1 phase in the combined
group (88.91 % ± 5.13 %) compared with the control
group (49.75 % ± 2.58 %). This increase suggested that
combination treatment of irradition and chloroquine sig-
nificantly promoted a cell-cycle arrest in G0/G1 phase.
IR with chloroquine synergistically induced apoptosis
To explore whether the synergistic cytotoxicity was
related to apoptosis, U87 GICs were processed with X-
ray(6Gy) or chloroquine(20 μM) alone or combination
of both for 24 h, and the induction of apoptosis was
assessed by AnnexinV-FITC/PI double staining. As
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shown in Fig. 2a-b, The percentage of early apoptotic
tumor cells(AnnexinV-FITC positive, PI negative) in the
combined treatment(35.06 % ± 6.98 %) was significantly
higher than that with radiation (16.73 % ± 4.52 %) or
chloroquine(6.94 % ± 1.21 %) alone.
To investigate the expression of proteins associated
with apoptosis in U87 GICs, we cultured cells with 6Gy
radiation or 20 μM chloroquine alone, or the two in
combination for 24 h. We The analyzed the expression
levels of apoptosis associated proteins from each group
by Western blotting. Combined treatment obviously
increased the expression of Caspase-3(Fig. 2c), and
decreased the expression of the antiapoptotic Bcl-2.
Chloroquine inhibits autophagy induced by IR
LC3-II could be seen in punctate structure mainly repre-
senting autophagosomes. The location of LC3 was
assessed by indirect immunofluorescence microscopy.
By fluorescence microscopy assay(Fig. 3a-b), the num-
bers of GICs with LC3+ puncta in the radiation alone
group (13 %) was obviously more than that in chloro-
quine alone (4 %) or control (2 %) group, and in com-
bined group (6 %), chloroquine significantly inhibited
the autophagy induced by IR. Moreover, to test whether
different treatments induced different autophagy in U87
GICs, we assessed the protein expression of LC3-II, a
mammalian homologue of ATG8 located in autophago-
somes. U87 GICs were treated with 6Gy IR or 20 μM
chloroquine alone, or the combination of the two for
48 h, and the ratio of the LC3-II/LC3-I were determined
by western blot. As shown in Fig. 3c-d, LC3-II level was
obviously enhanced in radiation group, and it was
significantly decreased by the combined treatment.
Chloroquine weakens the repair of radiation-induced DNA
damage in GICs
As one of pivotal mechanism involved in radioresistance
is DNA repair, the effects of chloroquine on radiation-
induced celluar genomic DNA damage were examined
by the alkaline comet assay. In our study, we assessed
Fig. 1 Effects of X-ray and chloroquine alone or combination on the viability of U87 GICs. a Human glioma cell line U87 GICs were plated
in 96-well plates(1 × 105/well), treated with various dose of X-ray or different concentration of chloroquine alone for 72 h. Cell viability
was examined by MTT assay. It demonstrated that X-ray and chloroquine suppressed cell viability in dose-dependent manner. Each bar
represents mean ± SD of triplicate determinations; results shown are representative of three identical experiments. b U87 GIC were plated
in 96-well plates(5 × 104/well), and treated with 6Gy X-ray or 20 μM chloroquine alone or combination. At indicated time points a MTT
assay was performed to assess the cell number, as measured by absorbance(OD). c Clonogenic survival 14 days after treatment with
radiation alone(0Gy to 8Gy), radiation plus chloroquine(20 μM). (*p < 0.05,**p < 0.05, n = 3). d Quantification of cell cycle distribution of
U87 GIC, using flow cytometry and PI, staining 48 h after treatment. Radiation combined chloroquine significantly increased number in
G0/G1 phase compared to radiotherapy alone group (*p < 0.05, **p < 0.05, n = 3)
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genomic DNA damage in GICs at 24 h after treatment.
We determined DNA damage by assessing the tail
length of the comet with a microscope. DNA damage
was more severe in the combined group than in IR or
chloroquine alone group at 24 h after treatment. The
data is demonstrated as the mean ± SD from more than
50 cells. Each group was analyzed in 3 times (Fig. 4b).
Then, chloroquine treatment was used to prevent the
repair of radiation-induced DNA damage.
Co-treatment inhibits self -renewal effect on U87 GICs
Sphere forming assay has been widely applied to moni-
tor the self-renewal ability of GICs. We observed the
combined treatment had strong inhibitory effects in
tumorsphere forming assays conducted as a stem cell
surrogate assay to measure the effect on clonogenic
cells. In this study, the combination of chloro-
quine(20 μM) and a 6Gy ionizing radiation turned out
to be very potent, probably because of the strong cyto-
static effect on GICs. As shown in Fig. 5, the number of
the tumorsphere in the combined treatment was signifi-
cantly smaller than that in chloroquine or IR alone
group. The diameter of tumorsphere (47 ± 8 μm) in the
combination was also smaller than that in chloroquine
(116 ± 9 μm) or IR (87 ± 11 μm) alone group.
Discussion
In the present study, we explored the radiosensitizing
action of an autophagy blocker chloroquine in GICs,
and aimed to further understand the molecular mecha-
nisms of its effect. We found that chloroquine or radi-
ation alone inhibited U87 GICs growth in a dose-
dependent manner. The combined inhibitory effect of
chloroquine and radiation on the viability of human
GICs was stronger than that of chloroquine or radiation
alone, in a synergetic way (Fig. 1a-c). The response of
GICs to radiation was associated with autophagy and the
late autophagy inhibitor chloroquine in combination
with radiation caused G0/G1 phase arrest, promoted
GICs’ apoptosis and impaired the repair of radiation-
induced DNA damage in GICs, and decreased the GICs’
tumorsphere numbers and diameters.
Recent researches demonstrated that cancer stem cells
could exploit autophagy to survive and accelerate their
renewal [16, 17]. GICs, as the most radioresistant cell
subset and autophagy targeting, may be helpful to cure
the disease [18, 19]. Our data indicates that irradiation
Fig. 2 Combination treatment of irradiation and chloroquine obviously promoted apoptosis in U87 GIC. a U87 GIC were treated with X-ray(6Gy)
alone and chloroquine(20 μM) alone or in combination for 24 h, and the promotion of apoptosis was measured using AnnexinV-FITC/PI double
staining. b Quantitative analysis of apoptotic cells. Data are demonstrated as the mean ± SD,*, p < 0.05, **p < 0.01, n = 3. c Apoptosis -associated
proteins were investigated by Western blotting. d Relative density of Bcl-2 and Cleaved caspase-3 versus GAPDH in each sample measured by
densitometry of the blots. Densitometric analysis of the immunoblot is expressed as a percentage of control. Data are presented as the mean ±
SD, *, p < 0.05 versus control, **p < 0.01, versus control, n = 3
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of U87 GICs results in enhanced autophagy. Chloro-
quine in combination with radiation inhibited the
autophagy induced by radiation and strongly promoted
GICs apoptosis. Apoptosis involved many diseases, espe-
cially malignant tumors. There are two main apoptotic
pathways: the extrinsic or death receptor pathway and
intrinsic or mitochondrial pathways [20]. Study finds
that radiation is a stimulus that initiate the intrinsic
pathway. The control and regulation of intrinsic pathway
is through members of Bcl-2 family of proteins [21].
Fig. 3 Irradiation obviously promoted autophagy and obviously enhanced autophagy associated proteins expression in U87 GICs, and
chloroquine can significantly inhibit the autophagy process which induced by radiation. a Representative images(×200) of the indicated regions
of U87 GICs, which analyzed for LC3 expression by immunofluorescence analysis. b Quantitative analysis of the number of cells with punctuate
GFP-LC3. c Authophagy-associated protein LC3 level in U87 GICs were examined by Western blotting. d Quantification of LC3 protein expression
in U87 GICs treated by indicated treatments after normalization with GAPDH levels. Mean ± SD. n = 3. (*, p < 0.05;**p < 0.01)
Fig. 4 Chloroquine weakens the repair of IR-induced genomic DNA damage in GICs. a GICs were treated radiation(6Gy) and chloroquine(20 μM)
and harvested at 24 h after radiation. The alkaline comet assay was used to measure treatment-induced DNA damage. Representative image of
U87 GICs at 24 h after different treatments are demonstrated (800 ×magnification). b The quantification of the percentage of cells with comet
tails at 24 h after treatment
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Here, we found that the combination of chloroquine and
radiation reduced anti-apoptotic Bcl-2, up-regulated
caspase-3, and enhanced the fraction of Annexin V-
FITC positive and PI negative cells to 35.1 %. However,
about 16.7 and 6.9 % respectively were measured with
treatment of radiation or chloroquine alone (Fig. 2).
These results may suggest that the combined inhibitory
effect cause apoptosis at least in part by the intrinsic
pathway. These results demonstrate that chloroquine
plays a synergetic role in radiation-induced viability in-
hibition and apoptosis in U87 MG GICs. The result may
be helpful to explaining the results of a clinical trial that
chloroquine, added to a comprehensive therapeutic
protocol (operation plus radiotherapy and chemother-
apy) for glioblastoma, significantly prolonged the median
overall survival compared with control groups [22].
Other study on the combining of radiation with chloro-
quine for the management of recurrent glioblastoma val-
idated the feasibility of the regimen and the authors
reported encouraging therapy outcomes [23].
Growing evidences suggest that chloroquine is a
strong anticancer drug in managing several cancers,
such as leukemia and hepatocarcinoma [24, 25]. Yuan et
al. showed that suppression of ATG5 by siRNA or sup-
pression of autophagy using 3-methylademine enhanced
the radiosensitisation action of gliomas after STAT3 sup-
pression [26]. Other research demonstrated that high ex-
pression levels of early growth response 1, which
induces autophagy, is produced by the resistant clones
of GICs [27]. In addition, mitochondrial isoenzyme of
NADP + −dependent isocitrate dehydrogenase siRNA-
transfected A172 glioma cells were sensitised after
suppression of autophagy [28]. Firat, E et al. also demon-
strated that induced-autophagy effects of PI3K/Akt path-
way inhibitors obviously prevent cell death induction in
γ-irradiated GICs, however, chloroquine significantly
promotes γIR-induced cell death in highly radioresistant
GICs [29]. Our study should be of high clinical signifi-
cance, one reason is all data presented are focused on
GICs, a population thought to be pivotal, because for
cancer progression and therapy resistance that must be
uproot in order to obtain long-term recurrence-free sur-
vival, another reason is that a clinically applicable late
autophagy inhibitor was used. However, the present
study has two limitations. First, our data presented here
have been obtained from cell lines, not from patients’s
tumor-derived stem-like cells. Second, the further
experimentation with animal models and clinical trials
were not investigated in this study.
Conclusion
We have shown that inhibition of autophagy in combin-
ation with radiation is a promising therapeutic strategy for
targeting GICs. The radiosensitization efficiency of chloro-
quine is obtained by inhibiting autophagy, weakening the
capacity for DNA repair in the early stage and promoting
cell-cycle arrest in addition to apoptotic responses.
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Fig. 5 Combination treatment of irradiation and chloroquine have synergistically effects on decreasing the GICs’ tumorsphere numbers and
diameters. a-d U87 GICs were treated as described before, then seeded in serum-free medium to generate tumorspheres,5 days after treatment,
we counted and photographed total tumorspheres (a control group, b chloroquine group, c radiation group, d conbination group). e Quantitative
analysis of the relative tumorsphere numbers treated by indicated treatments. f Quantitative analysis of the diameter of the tumorspheres treated
by indicated treatments. (*, p < 0.05, **p < 0.01)
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